| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.004 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.008 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |